ZBH: Adding Zimmer Biomet to Investing Ideas (Long Side)

09/04/18 03:50PM EDT

Below is a brief note from CEO Keith McCullough on why we're adding Zimmer Biomet (ZBH) to the long side of Investing Ideas today:

There's always a bull market somewhere and we have plenty of Healthcare ideas to choose from like TDOC and MD (when they are on sale).

Another name our independent Healthcare Research Team currently likes is Zimmer (ZBH). It’s down -1.5% on #decelerating volume today and signaling immediate-term TRADE oversold within a Bullish @Hedgeye TREND.

Top-down summary of the idea from Tom Tobin’s team:

“We believe the current valuation and consensus estimates do not reflect the potential for a turnaround under new management and resolution of self-inflicted manufacturing problems.”

I do like turnarounds. Buy on red,

KM
© 2024 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.